000 01503 a2200373 4500
005 20250516144846.0
264 0 _c20140331
008 201403s 0 0 eng d
022 _a1950-6007
024 7 _a10.1016/j.biopha.2013.03.011
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSzaflarski, Witold
245 0 0 _aNuclear localization of P-glycoprotein is responsible for protection of the nucleus from doxorubicin in the resistant LoVo cell line.
_h[electronic resource]
260 _bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_cJul 2013
300 _a497-502 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aATP Binding Cassette Transporter, Subfamily B, Member 1
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Nucleus
_xmetabolism
650 0 4 _aCytoplasm
_xmetabolism
650 0 4 _aDoxorubicin
_xpharmacokinetics
650 0 4 _aDrug Resistance, Multiple
650 0 4 _aHumans
650 0 4 _aNuclear Envelope
_xmetabolism
650 0 4 _aProtein Transport
700 1 _aSujka-Kordowska, Patrycja
700 1 _aJanuchowski, Radosław
700 1 _aWojtowicz, Karolina
700 1 _aAndrzejewska, Małgorzata
700 1 _aNowicki, Michał
700 1 _aZabel, Maciej
773 0 _tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_gvol. 67
_gno. 6
_gp. 497-502
856 4 0 _uhttps://doi.org/10.1016/j.biopha.2013.03.011
_zAvailable from publisher's website
999 _c22684725
_d22684725